The declaration foresees in particular to: bring together fragmented infrastructure and expertise supporting a shared and tangible goal “One million genomes accessible in the EU by 2022”; leverage and maximise the investments already made by Member States at national and EU level, particularly in sequencing, bio banking and data infrastructure; reaching a larger cohort that will provide a sufficient scale for new clinically impactful research.